Vitamin D and primary hyperparathyroidism (PHPT).

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annales d'Endocrinologie

• Publication date

  2012-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ando.2012.04.008PMID 22677209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin-D

  2020cited by this paper
• Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values.

  2012cited by this paper
• Measurement uncertainty of 25-OH vitamin D determination with different commercially available kits: impact on the clinical cut offs

  2010cited by this paper
• Biochemical effects of calcifediol supplementation in mild, asymptomatic, hyperparathyroidism with concomitant vitamin D deficiency

  2009cited by this paper
• Global vitamin D status and determinants of hypovitaminosis D

  2009cited by this paper
• Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

  2009influential reference
• Analysis of CYP27B1, Encoding 25‐Hydroxyvitamin D‐1α‐Hydroxylase, as a Candidate Tumor Suppressor Gene in Primary and Severe Secondary/Tertiary Hyperparathyroidism

  2009cited by this paper
• Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

  2009cited by this paper
• Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D.

  2009cited by this paper
• Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

  2009cited by this paper
• Global vitamin D status and determinants of hypovitaminosis D

  2009cited by this paper
• Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

  2009cited by this paper
• Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.

  2009cited by this paper
• Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism

  2008cited by this paper
• Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling.

  2008cited by this paper
• Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.

  2008influential reference
• Vitamin D status affects osteopenia in postmenopausal patients with primary hyperparathyroidism.

  2008cited by this paper
• Preoperative vitamin D replacement therapy in primary hyperparathyroidism: safe and beneficial?

  2008cited by this paper
• Long-term Outcome after Parathyroidectomy in Patients with Advanced Primary Hyperparathyroidism and Associated Vitamin D Deficiency

  2008cited by this paper
• Vitamin D deficiency.

  2007cited by this paper
• Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.

  2007cited by this paper
• Impact of 25 hydroxyvitamin D deficiency in perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.

  2007cited by this paper
• Correlations between Vitamin D Status and Biochemical/Clinical and Pathological Parameters in Primary Hyperparathyroidism

  2006cited by this paper
• Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas.

  2006cited by this paper
• A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism

  2006cited by this paper
• Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.

  2006cited by this paper
• Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.

  2005cited by this paper
• Activity and function of the nuclear factor kappaB pathway in human parathyroid tumors.

  2005cited by this paper
• Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism

  2005cited by this paper
• 25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy.

  2005cited by this paper
• Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy.

  2004cited by this paper
• The effect of vitamin D status on the severity of bone disease and on the other features of primary hyperparathyroidism (pHPT) in a vitamin D deficient region

  2004cited by this paper
• Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas.

  2003cited by this paper
• Multifactorial risk profile for bone fractures in primary hyperparathyroidism

  2002cited by this paper
• Molecular pathogenesis of primary hyperparathyroidism.

  2002cited by this paper
• Primary Hyperparathyroidism Revisited in Menopausal Women with Serum Calcium in the Upper Normal Range at Population-based Screening 8 Years Ago

  2002cited by this paper
• Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1–84: Implications for Improvement of Accurate Assessment of Parathyroid Function

  2001cited by this paper
• Vitamin D Receptor Status in Parathyroid Adenomasc

  2001cited by this paper
• Vitamin D status and redefining serum parathyroid hormone reference range in the elderly.

  2001cited by this paper
• Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications.

  2001cited by this paper
• Vitamin D receptor status in parathyroid adenomas.

  2001cited by this paper
• Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications.

  2000cited by this paper
• Bone mineral density increases with vitamin D repletion in patients with coexistent vitamin D insufficiency and primary hyperparathyroidism.

  2000cited by this paper
• The effects of vitamin D insufficiency in patients with primary hyperparathyroidism.

  1999cited by this paper
• Vitamin D receptor genotype is associated with cortical bone loss in Japanese patients with primary hyperparathyroidism.

  1998cited by this paper
• Rat calcium-sensing receptor is regulated by vitamin D but not by calcium.

  1996cited by this paper
• Vitamin D receptor genotypes in primary hyperparathyroidism

  1995cited by this paper
• Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.

  1992cited by this paper
• Immunochemiluminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism.

  1991cited by this paper
• Performance and diagnostic application of a two-site immunoradiometric assay for parathyrin in serum.

  1989cited by this paper
• Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay.

  1988cited by this paper
• Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

  1987cited by this paper
• Histologic parathyroid abnormalities in an autopsy series.

  1986cited by this paper
• Vitamin D: metabolism and biological actions.

  1984cited by this paper
• Vitamin D deficiency.

  1979cited by this paper

• Vitamin D Increases Irisin Serum Levels and the Expression of Its Precursor in Skeletal Muscle

  2023cites this paper
• Hyperparathyroidism and Vitamin D: Relationship Difficulties

  2022cites this paper
• Pitfalls in the Diagnosis of Primary Hyperparathyroidism in a Sudanese Adolescent Boy; a case disguised as rickets

  2022cites this paper
• High prevalence of low vitamin D levels in endocrine disorders

  2022cites this paper
• The skeletal actions of parathyroid hormone in primary hyperparathyroidism

  2021cites this paper
• Role of vitamin D supplements in prevention of hungry bone syndrome after successful parathyroidectomy for primary hyperparathyroidism: A prospective study

  2020cites this paper
• Parathormone Levels in a Middle-Eastern Healthy Population Using 2nd and 3rd Generation PTH Assays

  2020influential citation
• Evaluation of hemorheological parameters as biomarkers of calcium metabolism and insulin resistance in postmenopausal women

  2020cites this paper
• Vitamin D and endocrine disorders: routine laboratory diagnostic implications

  2018cites this paper
• The Impact of Vitamin D Status on Preoperative Ultrasound Findings and Parathyroidectomy Outcomes in Patients With Primary Hyperparathyroidism

  2017cites this paper
• Parathyroidectomy: is vitamin D a player for a good outcome?

  2016cites this paper
• Letter: Primary Hyperparathyroidism after Roux-en-Y gastric Bypass

  2016cites this paper
• Beneficial Effects of Taekwondo Poomsae Training on the Elderly: A Literature Review

  2016cites this paper
• Metabolism and Measurement of Parathyroid Hormone

  2015cites this paper
• PTH Assays and Their Clinical Significance

  2015cites this paper
• Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease.

  2014cites this paper
• Subclinical and asymptomatic parathyroid disease: implications of emerging data.

  2013cites this paper
• The Skeletal Actions of Parathyroid Hormone in Primary Hyperparathyroidism and in Osteoporosis

  2013cites this paper
• Further insights into the pathogenesis of primary hyperparathyroidism: a nested case-control study.

  2013cites this paper